- Home
- AAPG vs GTX Comparison
AAPG vs GTX Comparison
Compare AAPG & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAPG | GTX |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.5B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AAPG | GTX |
|---|---|---|
| Price | $23.88 | $18.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $48.50 | $20.00 |
| AVG Volume (30 Days) | 1.7K | ★ 2.4M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | N/A | ★ 20.63 |
| EPS | N/A | ★ 1.52 |
| Revenue | N/A | ★ $3,584,000,000.00 |
| Revenue This Year | N/A | $4.80 |
| Revenue Next Year | $368.64 | $3.57 |
| P/E Ratio | ★ N/A | $11.99 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $17.56 | $7.02 |
| 52 Week High | $48.45 | $21.42 |
Technical Indicators
Market Signals| Indicator | AAPG | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 39.06 |
| Support Level | $23.06 | $17.70 |
| Resistance Level | $26.01 | $19.28 |
| Average True Range (ATR) | 0.93 | 0.69 |
| MACD | 0.13 | -0.28 |
| Stochastic Oscillator | 62.79 | 13.45 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.